Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series

Affiliations

• ¹ Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
• ² Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
• ³ Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
• ⁴ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
• ⁵ Department of Investigational Cancer Therapeutics, and The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
• ⁶ Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.